new fda regulations for semaglutide approves first-ever oral GLP-1RA obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults FDA Accepts NDA Submission for

Cyclic vomiting syndrome (CVS), defined as recurrent episodic episodes of nausea and vomiting, should also be considered during the patient history-taking

Importantly, the weight-reducing efficacy appears comparable to that observed in common, polygenic obesity, as preliminarily evidenced by subgroup analyses from large trials such as SURMOUNT-1

Thats where amino acids come in

Does Ozempic damage the liver

Taking the medication with food can significantly reduce its effectiveness

The key adjustments for restaurant dining: ask for a takeout container at the start of the meal and set aside half the entree before eating (restaurant portions are almost always too large for the Retatrutide protocol)